Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Clinical trial NCT04933552 · RECRUITING
Trial details
- NCT number
- NCT04933552
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-15
- Primary completion
- 2032-05-31
- Enrollment
- 867
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.